Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Spanish reimbursement system

- PMLiVE

Accelerating diagnosis in rare disease

Biopharmaceutical companies can drive effective partnerships and improve outcomes for all stakeholders and patients in the area of rare disease.

- PMLiVE

Is agile working benefiting the employee or the organisation?

The late Stephen Hawking’s quote, “Intelligence is the ability to adapt to change” really resonates with me when thinking about agile working.We are undoubtedly living through a fundamental transformation in...

No incentive for a cure

The paradox of ‘cost-effective but unaffordable’ life-saving medicines

- PMLiVE

Pfizer’s plans for Inlyta go awry with failed adjuvant trial

Interim data suggested there was no improvement on disease-free survival compared to placebo

- PMLiVE

Parexel launches medical writing solutions business

Will develop a variety of communication services

- PMLiVE

No one is listening to you!

We know it is harsh but you know how frustrating it is. You want them to embrace change but they’ve got cloth ears. That’s why we have produced a guide,...

Page & Page Health

The challenges of making genomics a reality for patients

Collaboration is key

How can pharma engage with key decision-makers in new, collaborative NHS care models?

Paul Midgley, Sue Thomas, Steve How and Oli Hudson, of Wilmington Healthcare, explore how pharma should adapt its approach

Wilmington Healthcare

- PMLiVE

Merck’s Keytruda scores in frontline lung cancer yet again

Drug improved overall survival as a monotherapy, which rival BMS’ Opdivo was unable to show

- PMLiVE

AbbVie’s upadacitinib aces phase III trial

Arthritis drug outperformed both placebo and Humira in the study

- PMLiVE

Boehringer builds in immuno-oncology with €1.1bn-plus OSE deal

Offers €15m upfront for the anti-SIRP-alpha antibody and €15m when it reaches phase I testing

The two ‘c’s’ of public health: confounding and causal inference*

Rerum cognoscere causas. This phrase translates as ‘to know the causes of things’. It is the basis and impetus of public health. But epidemiologists have a different word for it:...

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links